Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Alopecia Clinical Trials
Alopecia clinical trials are recruiting across 86 cities. Here are the cities with the most active studies:
Alopecia Trial Phases
26 research organizations are sponsoring alopecia trials.
About Alopecia
Alopecia refers to hair loss from any part of the body, with alopecia areata being an autoimmune form causing patchy hair loss. It can range from small patches to total body hair loss. Treatments include JAK inhibitors, corticosteroids, and immunotherapy.
Clinical trials are advancing new treatments for alopecia. Currently, 35 studies are recruiting a combined 12,269 participants across the United States. Research is being conducted by 26 organizations including CorEvitas, AbbVie, Pfizer and 23 others.
2026 Alopecia Research Landscape
As of July 2026, the alopecia clinical trial landscape includes 35 actively recruiting studies across 86 cities in the United States. These studies are collectively seeking 12,269 participants, with an average enrollment target of 351 per study.
The research spans multiple phases of development: 13 studies are in NA, 9 studies are in PHASE2, 5 studies are in PHASE3, 2 studies are in EARLY_PHASE1, 2 studies are in PHASE1, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some alopecia treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 26 different organizations, including CorEvitas, AbbVie, Pfizer, Eli Lilly and Company, Veradermics, Inc., and 21 others. The large number of sponsors reflects significant research interest and investment in alopecia treatment advancement.
Geographically, alopecia trials are most concentrated in Birmingham, Alabama (5 trials); New York, New York (5 trials); Fremont, California (4 trials); Los Angeles, California (3 trials); San Diego, California (3 trials) and 7 other cities.
Featured Alopecia Studies
Highlighted recruiting studies for alopecia, selected by enrollment size and research scope.
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and face, but hair loss can happen on any part of the body. The purpose of this study is to assess how safe, effective, and tolerable upadacitinib is in adolescent and adult participants with severe AA. Upadacitinib is an approved drug being investigated f...
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the countr...
Frequently Asked Questions About Alopecia Clinical Trials
Are there alopecia clinical trials near me?
Yes, there are 35 alopecia clinical trials currently recruiting across 86+ cities in the United States, including Birmingham, Alabama; New York, New York; Fremont, California. Browse the studies above to find one at a location convenient for you.
How do I join a alopecia clinical trial?
To join a alopecia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are alopecia clinical trials free?
Yes, participation in alopecia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of alopecia treatments are being studied?
Current alopecia clinical trials are testing a range of approaches across NA (13 studies), PHASE2 (9 studies), PHASE3 (5 studies), EARLY_PHASE1 (2 studies), PHASE1 (2 studies), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 26 research organizations.
Is it safe to participate in alopecia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov